369
Participants
Start Date
October 31, 2015
Primary Completion Date
July 1, 2022
Study Completion Date
July 1, 2022
Enhanced Internet DA
BRCA1/2 carriers randomized to this arm will have access to Internet-based decision support including a preference clarification tool. This intervention is designed to provide education and decision support regarding the available risk management options.
Internet DA
BRCA1/2 carriers randomized to this arm will have access to Internet-based decision support. This intervention is designed to provide education regarding the available risk management options.
Enhanced Print DA
BRCA1/2 carriers randomized to this arm will receive print-based decision support materials which include a preference clarification tool. This intervention is designed to provide education and decision support regarding the available risk management options.
Print DA
BRCA1/2 carriers randomized to this arm will receive print education materials designed to provide information regarding the available risk management options.
Inconclusive Results DA
Women who receive uninformative BRCA1/2 results randomized to this arm will have access to Internet-based decision support including a preference clarification tool. This intervention is designed to provide education and decision support regarding the available risk management options.
Georgetown University Medical Center/Lombardi Comprehensive Cancer Center, Washington D.C.
National Cancer Institute (NCI)
NIH
National Human Genome Research Institute (NHGRI)
NIH
Georgetown University
OTHER